Skip to Content
Stock Analyst Update

GE on Solid Footing; We Raise FVE

We increase our General Electric fair value estimate to $15.10 from $14.10 previously, primarily due to interest rate tailwinds in GE’s pension liability, as well as time value of money.

Mentioned:

Despite the headline stock trade-off, narrow-moat-rated General Electric (GE) had a solid first quarter. We increase our fair value estimate to $15.10 from $14.10 previously, primarily due to interest rate tailwinds in GE’s pension liability, as well as time value of money. However, we also raised our fair value due to greater than expected progress in both healthcare and aviation’s margin profile (with the latter already hitting its 2021 target) in the first quarter, which itself was offset by weaker than expected top line revenue from aviation. With this latest raise, GE now is the cheapest name among our larger U.S. multi-industrials.

What disappointed us, however, was not commercial aerospace sales figures, where we still expect a second-half recovery, but rather military and systems sales. GE has maintained for quite some time that military orders have been there and that it just hasn’t delivered, so it’s certainly a watch item. In fairness, management did address the supply chain and rotorcraft delivery pressures on the call.

Considering GE's turnaround, we think a strong case could be made to increase our long-term earnings before interest growth assumption to be in line with peers (which would add about $1 to our fair value estimate). However, given what we perceive as mixed messaging on the timing of hitting the high-single-digit free cash flow margin (either in 2023 or just beyond), the headwinds related to GE ending its factoring program and unclear specific dynamics (we’re not alone here), as well as another major portfolio move that bears execution risk in the GECAS deal (as with any portfolio move), we prefer to see how the year develops before making such an adjustment.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Joshua Aguilar does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.